Related Experiment Video
Updated: Aug 6, 2026

Intramyocardial Cell Delivery: Observations in Murine Hearts
Published on: January 24, 2014
Myocardial viability in patients with coronary artery disease and left ventricular dysfunction: transplantation or
1Department of Medicine, University of Pennsylvania Health System, Philadelphia 19104-4283, USA.
Insights
Coronary artery bypass surgery improves survival in patients with coronary artery disease and left ventricular dysfunction. Imaging tests help identify "hibernating" myocardium, guiding treatment choices between revascularization and transplantation.
Area of Science:
- Cardiology
- Medical Imaging
- Cardiac Surgery
Background:
- Coronary artery bypass surgery (CABG) improves survival in patients with coronary artery disease (CAD) and left ventricular dysfunction (LVD) compared to antianginal therapy alone.
- The mechanisms behind this survival benefit, particularly the role of "hibernating" myocardium, require further elucidation.
- An increasing number of patients with CAD and LVD are referred for cardiac transplantation due to improved transplant survival rates, often bypassing revascularization options.
Purpose of the Study:
- To systematically investigate the mechanisms of survival advantage in revascularization therapy for patients with CAD and LVD.
- To evaluate the role of "hibernating" myocardium in improving left ventricular function and heart failure symptoms post-revascularization.
- To assess the utility of various imaging modalities in predicting myocardial recovery and guiding treatment decisions between revascularization and cardiac transplantation.
Main Methods:
- Review of recent advancements in imaging modalities for detecting hibernating myocardium.
- Analysis of positron emission tomography, thallium imaging, and dobutamine echocardiography for predicting recovery of myocardial dysfunction.
- Exploration of newer techniques such as 99mTc-sestamibi, contrast echocardiography, nuclear magnetic resonance spectroscopic imaging, and ultrasonic tissue characterization.
Main Results:
- Recently developed imaging modalities reliably predict regional myocardial dysfunction recovery after revascularization in hibernating heart areas.
- These imaging techniques are crucial for identifying viable myocardium, which can significantly improve left ventricular function.
- The choice between transplantation and revascularization is increasingly influenced by the ability to detect myocardial viability.
Conclusions:
- Identifying hibernating myocardium using advanced imaging is essential for optimizing treatment strategies in patients with CAD and LVD.
- Accurate detection of myocardial viability guides decisions between revascularization and cardiac transplantation, especially in the context of cost containment.
- Further research into the mechanisms of survival advantage and the cost-effectiveness of imaging modalities is warranted.
Abstract:
Coronary artery bypass surgery performed in patients with coronary artery disease and left ventricular dysfunction improves survival compared with antianginal therapy alone. The mechanisms for this survival advantage with revascularization therapy have not been systematically elucidated. Many of these patients have "hibernating" myocardium secondary to chronic ischemia with the potential for substantial improvement in left ventricular function and heart failure symptoms following revascularization therapy. Nevertheless, as survival with cardiac transplantation continues to improve, a significantly larger number of patients with coronary artery disease and left ventricular dysfunction are being referred for cardiac transplantation in lieu of revascularization surgery. Recently developed imaging modalities, which include positron emission tomography, thallium imaging, and dobutamine echocardiography, can reliably predict recovery of regional myocardial dysfunction after revascularization in these areas of hibernating heart. New modalities to detect hibernating myocardium include 99mTc-sestamibi, contrast echocardiography, nuclear magnetic resonance spectroscopic imaging, and ultrasonic tissue characterization. In an era of medicine characterized by increased concern for cost containment and the judicious application of expensive technology, the choice of the most appropriate tests to detect viability is a growing challenge and is essential in the choice between transplantation and revascularization.

